rs16888589: Understanding Your Genetic Risk for Colorectal Cancer
The rs16888589 variant is a single nucleotide polymorphism (SNP) located in an intergenic region on chromosome 8. Research has identified a statistical association between this variant and an increased risk of developing colorectal cancer.
What each genotype means
Baseline risk profile
This genotype represents the baseline or reference state for this genetic variant. Research indicates that individuals with this genotype do not carry the specific risk-associated alleles linked to increased colorectal cancer susceptibility at this location.
This is the most common genotype observed in the general population.
Moderately increased risk
Carrying one copy of the risk-associated G allele is statistically associated with a 1.4-fold higher risk of developing colorectal cancer compared to those without the variant. This association is based on population-level studies and does not imply a diagnosis or certainty of disease development.
This genotype is found in a significant portion of the population, with the minor allele frequency reported at approximately 7.3%.
Elevated risk profile
Individuals with two copies of the G allele show a 1.9-fold higher statistical risk for developing colorectal cancer compared to those with the baseline genotype. While this variant is associated with increased risk, it is only one of many factors that contribute to overall health outcomes.
This genotype is less common than the heterozygous state, occurring in a smaller percentage of the population based on the reported minor allele frequency.
What is rs16888589?
The rs16888589 variant is a specific location in the human genome where a single DNA building block, or nucleotide, differs between individuals. Located on chromosome 8 at position 116,623,363 (GRCh38), this SNP is classified as intergenic, meaning it resides in the space between known protein-coding genes. While it does not sit within a gene itself, researchers study such variants because they often reside in regulatory regions that can influence how nearby genes are turned on or off. In the case of rs16888589, scientific literature suggests it may influence the expression of nearby genetic material, potentially affecting cellular processes related to growth and development.
Association with Colorectal Cancer
Large-scale genetic studies, including genome-wide association studies (GWAS), have investigated the link between rs16888589 and colorectal cancer. Statistical analysis indicates that individuals carrying the G allele at this position may have a higher risk of developing this condition compared to those who do not. Specifically, the presence of one or two copies of the G allele has been associated with a 1.4 to 1.9-fold increase in risk. It is important to understand that this is a statistical association observed in large populations, not a direct cause of the disease. Many factors, including lifestyle, environment, and other genetic variants, contribute to the overall risk of developing cancer.
Interpreting Your Results
If you have received information about your rs16888589 genotype, it is essential to view it in the proper context. This variant is only one small piece of a much larger, complex puzzle regarding cancer risk. Having a higher-risk genotype does not mean you will develop cancer, nor does having a lower-risk genotype guarantee you will not. Genetic testing for common variants like this is not a diagnostic tool. If you are concerned about your personal or family history of colorectal cancer, the most effective step is to consult with a healthcare professional or a genetic counselor. They can help you understand your overall risk profile based on your complete medical history and guide you toward appropriate screening recommendations.
How common is this variant?
The G allele is considered the minor allele at this locus, with a global minor allele frequency (GMAF) reported at approximately 0.07254.
Frequently asked questions
Does having the G allele mean I will get cancer?
No. This variant is associated with a statistical increase in risk, not a certainty of disease. Most people who carry this variant will never develop colorectal cancer.
Should I change my diet based on this result?
Genetic results should not be used to make medical or lifestyle changes without consulting a doctor. You should discuss your overall health and screening needs with a healthcare provider.
Is this a diagnostic test for cancer?
No. This SNP is a marker used in research to understand population-level risk. It is not a clinical diagnostic test for detecting or predicting cancer in an individual.
Where can I find more information on colorectal cancer screening?
You can visit reputable organizations like the Colorectal Cancer Alliance or consult your primary care physician to learn about recommended screening ages and methods.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16888589?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is associated with a 2-4 fold increased risk of developing V617F-associated myeloproliferative neoplasms (MPNs).
This variant in the CYP2R1 gene is associated with circulating 25-hydroxyvitamin D levels and, in rare cases, pathogenic variants in this gene can cause vitamin D-dependent rickets type 1B.
This variant is a highly associated risk factor for neuroblastoma susceptibility, residing in a super-enhancer within the LMO1 gene.
This SNP in the MS4A2 gene is associated with a 3-fold increased risk of predisposition to childhood asthma in Japanese populations.
This variant is a pathogenic mutation in the PKP2 gene associated with an increased risk of arrhythmogenic right ventricular dysplasia (ARVD) type 9.
This variant in the UCN2 gene is associated with phenotypic traits identified through genome-wide association studies.